FDA Drug-Eluting Stent Guidance Is Being Drafted – CDRH’s Foy

FDA guidance specifically addressing premarket guidelines for drug-eluting stents could be out by the end of the year, according to CDRH staff

More from Archive

More from Medtech Insight